Shares of Tharimmune are surging Thursday afternoon. The company on Wednesday announced positive results from a simulation analysis of its lead clinical asset, TH104.
Tharimmune (THAR) Shares Skyrocket On Promising Opioid Countermeasure Data
Where Today's News Shapes Tomorrow
